Rosa Klotz, André L Mihaljevic, Yakup Kulu, Anja Sander, Christina Klose, Rouven Behnisch, Maximilian C Joos, Eva Kalkum, Felix Nickel, Phillip Knebel, Frank Pianka, Markus K Diener, Markus W Büchler, Thilo Hackert
BACKGROUND: Open partial pancreatoduodenectomy (OPD) represents the current gold standard of surgical treatment of a wide range of diseases of the pancreatic head but is associated with morbidity in around 40% of cases. Robotic partial pancreatoduodenectomy (RPD) is being used increasingly, yet, no randomised controlled trials (RCTs) of RPD versus OPD have been published, leaving a low level of evidence to support this practice. METHODS: This investigator-initiated, exploratory RCT with two parallel study arms was conducted at a high-volume pancreatic centre in line with IDEAL recommendations (stage 2b)...
April 2024: The Lancet regional health. Europe